Category: Research
-
Why we fall for certain people
Attraction isn’t as random as it feels. This post explores the hidden science of romantic attraction—how biology, psychology and subconscious cues shape who we fall for. Learn what really drives your emotional chemistry, and how this knowledge can improve your relationships
-
Why I love Solution-Focused (Brief) Therapy as a counselling modality
Discover why Solution-Focused (Brief) Therapy is a respectful, evidence-based approach that centres client strengths, fosters hope, and works quickly. Lee Hopkins shares how SFBT complements neurodiverse and time-limited clients while offering profound change through deceptively simple, forward-focused conversations
-
Understanding the overlap between complex PTSD, autism, and ADHD
This article explores the overlapping traits and key differences between complex PTSD, autism, and ADHD. It explains how emotional dysregulation, sensory sensitivity, and suicidal ideation can present similarly—while offering clarity on diagnosis, misdiagnosis, and the need for tailored, trauma-informed, and neurodivergent-aware support
-
Bridging the gap in bipolar disorder research
A Dutch study compared 258 bipolar I disorder (BD-I) outpatients with participants from four clinical cohorts and a general population sample. While many characteristics aligned, outpatients were younger, more educated, and had higher comorbidity rates than some cohorts, highlighting potential selection biases in BD research generalisability.
-
Understanding quality of life in bipolar risk
A two-year study of 1,038 individuals at risk for bipolar disorder found significantly lower quality of life (QoL) compared to peers. Psychological QoL improved with risk reduction. Higher baseline functioning and self-management skills predicted better outcomes, highlighting the need for early interventions targeting coping strategies and risk monitoring
-
Bipolar disorder treatment trends
A 24-year study of 8,707 bipolar disorder inpatients in German-speaking countries found declining lithium use (45% to 30%) and rising second-generation antipsychotics (e.g., quetiapine). Antidepressants remained high (≥60%) despite guidelines, and lithium-treated patients received more medications. Findings highlight gaps between clinical practice and evidence-based recommendations.
